Screening compound: C21H19ClN4O2 (J107-0713)

Screening compound: C<sub>21</sub>H<sub>19</sub>ClN<sub>4</sub>O<sub>2</sub> (J107-0713)
Screening compound: C<sub>21</sub>H<sub>19</sub>ClN<sub>4</sub>O<sub>2</sub> (J107-0713) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C21H19ClN4O2 (J107-0713)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J107-0713

Molecular Formula

C21H19ClN4O2 (C21 H19 ClN4 O2)

Compound Name

N-(8-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-3,6-dimethyl-[1,2]oxazolo[5,4-b]pyridine-4-carboxamide

IUPAC name

N-(8-chloro-2349-tetrahydro-1H-carbazol-1-yl)-36-dimethyl-[12]oxazolo[54-b]pyridine-4-carboxamide

SMILES

Cc1noc2nc(C)cc(C(NC(CCC3)c4c3c3cccc(Cl)c3[nH]4)=O)c12

InChI

InChI=1S/C21H19ClN4O2/c1-10-9-14(17-11(2)26-28-21(17)23-10)20(27)24-16-8-4-6-13-12-5-3-7-15(22)18(12)25-19(13)16/h3,5,7,9,16,25H,4,6,8H2,1-2H3,(H,24,27)/t16-/m0/s1

InChI Key

ASZHZKWIHHRJTM-INIZCTEOSA-N

MDL Number (MFCD)

MFCD28578283

C21H19ClN4O2 (J107-0713) in Drug Discovery

Included in Screening Libraries

Antifungal Library (16415 compounds)

Antiviral Library (67538 compounds)

DGK Inhibitors Library (10558 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Antiviral
  • Infections
  • Immune system
Agro:
  • Agro
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C21H19ClN4O2 (J107-0713) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C21H19ClN4O2 (J107-0713)?
Check Price and Availability of C21H19ClN4O2 (J107-0713), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C21H19ClN4O2 (J107-0713) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C21H19ClN4O2 (J107-0713)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C21H19ClN4O2 (J107-0713)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C21H19ClN4O2 (J107-0713) available by request